Akriderm ointment for planks. approx. 0.05% tube 30g

Be the first to review this product

Special Price $8.82 Regular Price $16.00

In stock

SKU

OTC1020434

Dosage:

0.05% x 30g

0.05% + 0.1% + 1% x 15g

0.05% + 0.1% + 1% x 30g

Release form:

Cream

Ointment

Category

Psoriasis

Scope of the drug

Dermatology

Release form

Ointment

Manufacturer country

Russia

Package quantity, pcs

one

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Details

Description

Release form, composition and packaging

Ointment for external use 0.05% translucent, from white to white with a yellowish tinge.

100 g

betamethasone dipropionate in terms of 100% substance 0.064 g, which is equivalent to betamethasone 0.05 g, propyl parahydroxybenzoate - 0.05 g, liquid paraffin (vaseline oil) - 4 g, isopropyl myristate - 1 g, petroleum jelly - up to 100 g.

15 g - aluminum tubes (1) - cardboard packs.

30 g - aluminum tubes (1) - cardboard packs.

pharmachologic effect

GCS, has anti-inflammatory, antipruritic and vasoconstrictor effects. ''

Indications for use

- allergic skin diseases (including acute, subacute and chronic contact dermatitis, occupational dermatitis, solar dermatitis, neurodermatitis, pruritus, dyshidrotic dermatitis)

- acute and chronic forms of non-allergic dermatitis

- psoriasis.

Contraindications for use

- tuberculosis of the skin

- viral skin infections

- vaccination

- perioral dermatitis

- rosacea (rosacea)

- hypersensitivity to any component of the drug.

Dosage regimen

Akriderm should be applied in a thin layer to the affected areas 1-3 times / day, rubbing lightly.

The duration of treatment should be no more than 3 weeks.

The use of Akriderm in children under the age of 12 is carried out under the supervision of a physician.

Overdose

Symptoms: excessive or prolonged use of local GCS can cause inhibition of the function of the pituitary-adrenal system, which can lead to the development of secondary adrenal cortex insufficiency and the appearance of symptoms of hypercortisolism, including Cushing's syndrome.

Treatment: Appropriate symptomatic treatment is indicated.

Acute symptoms of hypercortisolism are usually reversible.

Correction of electrolyte imbalance is indicated if necessary.

In the case of chronic toxic effects, a gradual abolition of GCS is recommended.

Side effect

Possible: burning, irritation and dryness of the skin, folliculitis, hypertrichosis, hypopigmentation, allergic contact dermatitis, skin atrophy, striae and prickly heat.

In case of side effects, you should consult a doctor.

Drug interactions

There were no clinically significant interactions with other drugs.

Application during pregnancy and lactation

Due to the fact that the safety of using local corticosteroids in pregnant women has not been established, the use of drugs of this class during pregnancy is justified only if the benefits to the mother clearly outweigh the possible harm to the fetus.

Drugs in this group should not be used by pregnant women in large doses for a long time.

Since it has not yet been established whether glucocorticosterones, when applied topically and systemically absorbed, can penetrate into breast milk, a decision should be made to stop breastfeeding or to discontinue the drug, taking into account how necessary its use for the mother.

Special instructions In the absence of the effect of treatment within two weeks, it is recommended to consult your doctor in order to possibly clarify the diagnosis.

If irritation or hypersensitivity reaction is noted during the use of the drug, treatment should be discontinued and consult your doctor.

For secondary fungal or bacterial infections, appropriate medications should be used.

In the absence, at the same time, of a quick positive effect, the use of Akriderm should be discontinued until all signs of infection are eliminated.

Long-term use of the drug on the skin is not recommended.

Do not use Akriderm in the eye area, because

in this case, the development of cataracts, glaucoma, fungal infection and exacerbation of herpes infection is possible.

Use in pediatrics

Children may be more susceptible to the use of local GCS, which cause depression of the hypothalamic-pituitary-adrenal gland

Name ENG

AKRIDERM GK

Clinical and pharmacological group

GCS for local use + antibiotic aminoglycoside + antifungal agent

ATX code

Betamethasone in combination with other drugs

Dosage

0.05% x 30g

Structure

100 g of ointment contains: betamethasone dipropionate 64 mg, which corresponds to the content of betamethasone 50 mg.

Excipients: propyl parahydroxybenzoate - 0.05 g, liquid paraffin (vaseline oil) - 4 g, isopropyl myristate - 1 g, petroleum jelly - up to 100 g.

Indications

Treatment of steroid-sensitive dermatoses complicated by primary and / or secondary bacterial infection, eczema (atopic, childhood, coin-like), limited and diffuse allergic dermatoses, including those complicated by an infection sensitive to gentamicin, dermatitis (simple and allergic), atopic dermatitis, solar dermatitis, exfoliative and radiation dermatitis, diaper rash, psoriasis, itching.

INN / Active ingredient

betamethasone

Contraindications

Hypersensitivity to drug components.

Skin tuberculosis, viral skin infections, vaccinations, perioral dermatitis, rosacea (rosacea).

Storage conditions and periods

At a temperature of 15-25 degrees.

Expiration date: 4 years

Specifications